Key result
Epstein-Barr virus presence in South African children with Hodgkin's lymphoma was associated with less aggressive symptoms and significantly longer median survival compared to EBV negative patients.
Why the study?
Does Epstein-Barr virus (EBV) positivity improve survival in South African children with classical Hodgkin's lymphoma?
Cohort (n=47)
Does Epstein-Barr virus (EBV) positivity improve survival in South African children with classical Hodgkin's lymphoma?
In South African children with classical Hodgkin's lymphoma, EBV positivity is associated with less aggressive symptoms and longer median survival.
Should not yet alter management in pediatric Hodgkin lymphoma; hypothesis-generating for EBV as a prognostic marker in this population.
Aim—To study the distribution of Hodgkin9s lymphoma in South African children and report the incidence of Epstein-Barr virus (EBV) as regards age, race, sex, and histological subtype; to investigate whether EBV is relevant to survival. Methods—Immunohistochemistry (IHC) and in situ hybridisation (ISH) to detect EBV were performed on 47 South African children with classical Hodgkin9s lymphoma, ranging in age from 3 to 14 years and coming from different ethnic backgrounds. The correlation between the presence of the virus and clinical outcome was assessed. Results—The nodular sclerosing subtype predominated, comprising 89% of cases; the remaining 11% were of the mixed cellularity subtype. EBV was present in 68%. Full clinical data were available for 36 cases; EBV positive patients presented with less aggressive symptoms at diagnosis and had a significantly longer median survival than EBV negative patients. Conclusions—The distribution of EBV in South African childhood Hodgkin9s lymphoma follows a pattern intermediate to that of industrialised and non-industrialised countries. Furthermore, our data suggest that there is an association between poor prognosis and the non-detection of EBV products in South African childhood Hodgkin9s lymphoma.
No takes yet. Share an insight, caveat, or question.
Kase et al. (1980) conducted a cohort in Classical Hodgkin's lymphoma (n=47). Epstein-Barr virus (EBV) presence vs. EBV negative was evaluated on Median survival. Epstein-Barr virus presence in South African children with Hodgkin's lymphoma was associated with less aggressive symptoms and significantly longer median survival compared to EBV negative patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: